HOUSTON (PRWEB) April 30, 2018
OrthoAccel® Technologies, Inc. today announced that it has entered into an exclusive U.S. distribution agreement with Henry Schein Orthodontics to distribute AcceleDent® Optima™, an FDA-cleared, Class II medical device employing patented SoftPulse Technology® that produces gentle pulsating forces clinically shown to speed up bone remodeling. The agreement states that Henry Schein Orthodontics, one of the industry’s most trusted providers of innovative clinical solutions, will be the exclusive U.S. distributor of AcceleDent Optima. OrthoAccel is retaining its direct sales force and the hybrid distribution model is expected to expand the company’s market leadership.
“By working with Henry Schein Orthodontics, a leading global orthodontic company, OrthoAccel is expanding its market reach exponentially. This new distribution resource will complement OrthoAccel’s national sales team, who will continue to serve our existing customers and introduce new ones to the benefits of accelerated technology,” said David Josza, OrthoAccel’s president and CEO. “Demand for our technology is growing as leading orthodontists report improved predictability and tracking when integrating AcceleDent into their aligner therapy. By expanding our distribution resources, we can serve more practices.”
Josza adds that the Henry Schein Orthodontics distribution arrangement will focus on AcceleDent Optima, OrthoAccel’s third generation vibratory orthodontic device, which received FDA clearance in May 2017. Optima uses Bluetooth® technology and a cloud-based practice management system that enables orthodontists and clinical teams to connect with patients for more proactive case management. A small, lightweight, waterproof device, Optima is the first and only orthodontic device that connects patients and practices through usage monitoring, direct messaging and virtual awards via an app or web portal.
Patients use the handheld, prescription-only device for 20 minutes daily and the gentle vibrations from the device mouthpiece are clinically shown to speed up tooth movement by as much as 50 percent while reducing discomfort by up to 71 percent during orthodontic treatment with clear aligners or braces.
“We are proud to begin distributing AcceleDent Optima because it is a leading technology in the field of accelerated orthodontics, which complements our progressive practice solution offerings, like Sagittal first.” said Ted Dreifuss, general manager of Henry Schein Orthodontics. “Several clinical studies and case reports show that orthodontists are experiencing exciting clinical benefits with AcceleDent and that is outstanding.”
For more information about AcceleDent, visit AcceleDent.com or stop by booth 1033 at the 2018 American Association of Orthodontists Annual Session, May 4-8 in Washington D.C.
About OrthoAccel® Technologies, Inc.
OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the creation, manufacturing, marketing and sales of innovative solutions that enhance dental care and orthodontic treatment. Among the company’s innovations is AcceleDent® Optima™, an FDA-cleared, Class II medical device that employs patented SoftPulse Technology® that produces gentle pulsating forces that are shown to speed up bone remodeling. These safe and gentle vibrations accelerate tooth movement by as much as 50 percent and reduce discomfort associated with orthodontic treatment by up to 71 percent. Leading orthodontists from around the world report increased mechanical efficiency with orthodontic appliances and improved predictability of outcomes with AcceleDent. OrthoAccel, the Leader in Accelerated Orthodontics, has been ranked on Deloitte’s Technology Fast 500 as one of the fastest growing companies in North America for three consecutive years. OrthoAccel is based in Houston, Texas and maintains a global presence through its EMEA office in Essen, Germany. To learn more about OrthoAccel’s focus on improving the journey to healthy, beautiful smiles, visit AcceleDent.com.